Stanford researchers have developed chemically modified AAV vectors through an unnatural amino acid substitution on the capsid surface for post-production vector engineering through biorthogonal copper-free click chemistry.
The Nicolls Lab at Stanford University has discovered P-selectin inhibitors as a possible treatment for lymphedema. Lymphedema affects more than 200 million people in the world and currently has no approved pharmacological therapies.
Stanford researchers in the Benson Lab have developed CCSNet, an open source software platform for modeling CO2 storage reservoirs based on machine learning neural networks.
Stanford inventors have developed an early-stage screening method to diagnose abdominal aortic aneurysms (AAA). AAA is a common cardiovascular disease with high prevalence in European men 65 years and above.
Researchers at Stanford have developed a next-generation technique of fabricating metal oxide thin films using open-air ultrasonic spray combustion and plasma curing.
Stanford researchers have developed a new method of imaging cholesteatoma, an expanding and destructive lesion of the middle ear and mastoid, based on its chemical composition.
Stanford scientists have invented a new PET-nanophotonic metamaterial scintillator that consists of tunable scintillating alkaline-earth rare-earth fluoride nanoparticles (MLnF) for low-dose, high-resolution PET imaging.
Stanford researchers in the Bao lab have developed a new fabrication method to create stretchable transistors for electronic skin. It produces a soft, stretchable material capable of sensing pressure, temperature, strain, and more.
Researchers at CZ Biohub SF and Stanford have developed unique fusion proteins that have broad therapeutic benefits for the treatment of infection by existing and future coronaviruses.
Researchers at Stanford have developed an innovation that will enhance the depth of the imaging capabilities for optical coherence tomography (OCT) imaging.